Dr. Romeo Galang joined Grady in 2017 and continues to serve as an adjunct assistant professor in the Emory University School of Medicine, Department of Gynecology and Obstetrics. In addition to clinical service, Dr. Galang is a Medical Officer in the National Center on Birth Defects and Developmental Disabilities (NCBDDD) at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, where he serves as clinical lead for CDCÛªs Zika pregnancy and infant research and surveillance activities. Since joining CDC in 2014 as an Epidemic Intelligence Service Officer, Dr. Galang has served in public health emergency responses to Ebola in West Africa, HIV in Cambodia and Indiana, and to Zika virus in the Americas. Dr. Galang holds degrees in medicine and public health from the University of Rochester and Tulane University, respectively. He completed residency training in Obstetrics and Gynecology at the Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA. Dr. Galang’s current interests include Zika virus, pregnancy and birth defect surveillance, and the role of maternal and child health experts in public health emergency responses.
Dr. Romeo R. Galang, MD, MPH
Specialties
- Obstetrics/Gynecology
Board Certifications
- ABMS Obstetrics/Gynecology
Affiliations
- Emory
Education & Training
- Medical School: University of Rochester School of Medicine & Dentistry
- Residency: Brigham and Women's Hospital
Honors & Awards
Alpha Omega Alpha Medical Honor Society
BWH/MGH Humanism in Medicine Award
BWH/MGH Clinical Teaching Award in Obstetrics and Gynecology
Delta Omega Honorary Society in Public Health
CDC Charles C. Shepard Science Award
CDC Honor Award - Excellence in Emergency Response, Domestic
CDC Honor Award - Excellence in Frontline Public Health
CDC Honor Award - Excellence in Program Delivery
Publications
CDC. Possible Zika Virus Infection Among Pregnant Women - United States and Territories, May 2016. MMWR Morb Mortal Wkly Rep 2016;65.
CDC. Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak - Puerto Rico, 2016. MMWR Morb Mortal Wkly Rep 2016;65:311-314.
CDC. Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep 2016;65:211-214.
CDC. Cluster of HIV Infections Attributed to Unsafe Injection Practices - Cambodia, December 1, 2014-February 28, 2015. MMWR Morb Mortal Wkly Rep 2016;65:142-145.
CDC. Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65(Early Release):1-6.
CDC. Community outbreak of HIV infection linked to injection drug use of oxymorphone - Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(16):443-4.
Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV Infection Linked to Injection Drug Use of Oxymorphone: Indiana, 2014-15. New England Journal of Medicine. 2016. In Press.
Galang RR, Smith DK, Mendoza M. HIV Preexposure Prophylaxis Among U.S. Adults: Awareness of and Willingness to Recommend or Take-HealthStyles Surveys, 2009-2014. In Clearance.
Galang RR, Peters PJ, Switzer W, et al. HCV phylogenetic analysis identifies candidates for HIV partner services in an HIV outbreak setting - Indiana, 2015. In Progress.